What Is Ketamine-Assisted Psychotherapy

A medication originally designed to keep surgical patients unconscious has quietly become one of the most talked-about mental health treatments in Canada. Ketamine assisted psychotherapy pairs sub-anaesthetic doses of this controlled substance with guided therapeutic sessions to treat conditions that haven't responded to conventional care. The science is promising, the risks are real, and the line between medical breakthrough and potential misuse deserves a closer look.

Key Takeaways

• You'll Learn that ketamine psychotherapy works through a three-phase structure of preparation, dosing, and integration, and that skipping any phase undermines the treatment's effectiveness.
• You'll Learn how ketamine's action on glutamate receptors creates a brief window of heightened neuroplasticity that trained therapists use to rewire entrenched thought patterns.
• You'll Learn that Health Canada classifies ketamine as a Schedule I controlled substance, and its use for mental health remains off-label, meaning clinics operate under strict provincial regulations.
• You'll Learn why addiction risk cannot be dismissed during ketamine assisted therapy, especially for individuals with a history of substance use disorders.

How Does Ketamine-Assisted Psychotherapy Work?

Ketamine assisted psychotherapy combines a carefully measured dose of ketamine with structured therapeutic support. The treatment is not a single event. It unfolds across three distinct phases, each serving a specific clinical purpose.

Preparation begins days or weeks before the dosing session. A therapist meets with you to map your mental health history, set intentions for treatment, and build the trust needed to do difficult emotional work under an altered state of consciousness. This groundwork separates ketamine assisted therapy from recreational use, where the drug is consumed without clinical framing or psychological support.

The dosing session itself lasts between two and four hours. You receive ketamine through an intravenous drip, intramuscular injection, or sublingual lozenge, depending on the clinic and your medical profile. The dose sits well below anaesthetic levels. You remain semi-conscious, eyes covered, listening to curated music. A therapist stays in the room throughout, offering guidance if emotions surface and monitoring your physical safety.

Integration happens in the days following the session. This is where the real therapeutic work lives. You meet with your therapist to examine what came up during the dosing experience, connect it to the patterns driving your distress, and translate those insights into changes you can sustain. Without integration, the neurological benefits of ketamine fade within weeks.

Most treatment protocols involve four to six sessions spaced over several weeks. The spacing matters because it gives your brain time to consolidate new neural pathways between doses.

What Happens in Your Brain During Ketamine Therapy?

Ketamine works through a pathway that looks nothing like traditional antidepressants. SSRIs and SNRIs target serotonin or norepinephrine and take weeks to produce noticeable effects. Ketamine acts on a different neurotransmitter system entirely, and it can produce measurable changes within hours.

The drug blocks NMDA receptors, which regulate glutamate, the brain's most abundant excitatory neurotransmitter. This blockade triggers a surge in BDNF, a protein that fuels synaptic repair and new cell growth. The result? A temporary spike in neuroplasticity, your brain's ability to form new connections and rewire existing ones.

For someone locked in treatment-resistant depression, this matters enormously. Depression can physically shrink synaptic connections in the prefrontal cortex, the region responsible for decision-making, emotional regulation, and future planning. Ketamine psychotherapy gives the brain raw material to rebuild those connections as a therapist helps direct where the new wiring goes.

The dissociative state ketamine produces also plays a therapeutic role. It creates distance between you and your habitual thought patterns. Traumatic memories that ordinarily trigger panic can be examined with a degree of emotional detachment. Rigid self-narratives loosen enough to be questioned. This isn't escapism. Under clinical supervision, that temporary distance becomes a tool for working through experiences that talk therapy alone couldn't reach.

Who Can Benefit from Ketamine-Assisted Therapy?

Ketamine assisted therapy was built for people who've already tried the standard options and hit dead ends. The strongest clinical evidence supports its use in treatment-resistant depression, meaning cases where two or more antidepressant medications have failed to produce adequate relief.

Research also shows promise for post-traumatic stress disorder, severe anxiety, obsessive-compulsive disorder, and chronic pain conditions with psychological components. Clinicians in Canada increasingly consider this treatment when a patient's suffering continues despite medication adjustments, years of talk therapy, and lifestyle interventions.

Not everyone qualifies. Active psychosis, uncontrolled high blood pressure, a history of aneurysms, and certain cardiac conditions all rule out ketamine assisted psychotherapy. Pregnancy is an absolute contraindication. And here's the tension that matters most for our readers. A personal history of substance use disorders demands extreme caution.

What Are the Risks and Side Effects?

Every dosing session carries predictable short-term effects. Nausea, dizziness, elevated blood pressure, and perceptual disturbances hit most people during the infusion and resolve within an hour or two. Some patients describe the dissociative experience as unsettling or frightening, particularly during early sessions before they know what to expect.

The longer-term concerns carry more weight. Repeated ketamine use, even at sub-anaesthetic doses, can irritate the bladder lining and cause urinary symptoms. Cognitive effects from extended treatment courses remain under investigation, with some researchers flagging potential impacts on memory and attention.

Then there's the addiction question. Ketamine is a Schedule I controlled substance under Canada's Controlled Drugs and Substances Act for a reason. It produces euphoria, dissociation, and altered perception, a combination that carries genuine abuse potential. Clinical dosing protocols reduce this risk through supervised administration, careful dose control, and limited treatment courses. But the risk isn't zero.

People with a history of substance use disorders face heightened vulnerability. The dissociative relief ketamine provides can feel remarkably similar to the escape that drew them toward substances in the first place. How addictive is ketamine depends on the individual, the dosing frequency, and the presence of clinical safeguards, but dismissing the concern outright would be irresponsible.

How Is Ketamine Therapy Regulated in Canada?

Health Canada approved ketamine exclusively as an anaesthetic. Its application for depression, PTSD, anxiety, or any other mental health condition falls under off-label prescribing. This means a licensed physician can legally prescribe it for these purposes based on clinical judgement and emerging evidence, but no federal regulator has formally endorsed that use.

Provincial medical colleges set the ground rules. In Ontario, for example, off-label ketamine use falls under complementary and alternative medicine guidelines. Clinics must follow strict protocols for patient screening, drug handling, storage, documentation, and post-administration monitoring. Physicians who prescribe ketamine outside these guardrails risk disciplinary action.

Esketamine, marketed as Spravato, earned Health Canada approval in 2020 specifically for treatment-resistant depression. It's the only ketamine-based product with an on-label mental health indication in Canada. Administration requires a certified clinic, and patients must remain under observation for at least two hours after each dose.

Cost creates another barrier. What is ketamine therapy going to cost you out of pocket? Sessions range from $500 to $1,500 each, and OHIP does not cover them. Some private insurance plans reimburse portions of the psychotherapy component, but drug costs and medical supervision fees rarely qualify. A full treatment course of six sessions can run $3,000 to $9,000 before aftercare. Stopping treatment abruptly or using ketamine outside a supervised protocol can trigger withdrawal symptoms of ketamine that derail recovery and add unexpected costs to an already expensive treatment.

What Should People in Recovery Know Before Considering This Treatment?

This question deserves its own space because the stakes are different for anyone with a substance use history. Ketamine assisted psychotherapy introduces a mood-altering controlled substance into the life of someone who may have spent years learning to live without one.

The argument in favour is straightforward. Untreated depression and PTSD are among the most powerful drivers of relapse. If conventional treatments have failed and ketamine could stabilise your mental health, the therapeutic benefit might outweigh the substance use risk. Some addiction specialists hold this view.

The argument against carries equal weight. Ketamine produces a subjective high. It creates a learned association between consuming a substance and feeling better. For someone whose brain has been sensitised by previous addiction, that association can rekindle patterns they've worked hard to extinguish. Withdrawal symptoms range from cravings and anxiety to cognitive difficulties, and they can emerge even from medically supervised courses.

If you're in recovery and considering this treatment, a few safeguards matter.

• Full disclosure of your substance use history to the prescribing physician and therapist
• Involvement of your addiction counsellor or sponsor in the decision
• Agreement on a hard limit for the number of sessions before reassessment
• Monitoring for any change in your relationship with the drug, such as counting days until the next dose

The Canadian Centre for Addictions provides ketamine addiction treatment for individuals who've moved from prescribed or recreational ketamine use into dependency. With facilities in Port Hope and Cobourg, Ontario, and a clinical team that includes physicians, psychotherapists, and certified addiction counsellors, CCFA treats ketamine dependency alongside the mental health conditions that may have led to it. Programmes run from 30 to 90 days and include lifetime aftercare.

FAQ